| |
|
|
|
LA Jolla Pharma  
|
|
5.72 0.71 (0.14%) |
06-05 10:45 |
|
Open: |
5.55 |
Pre close: |
5.01 |
Target:
|
7.77
|
|
High: |
5.88 |
Low: |
5.41 |
Resistance:
|
6.65
8.10
|
|
Volume: |
611,422 |
Market Cap: |
156M |
Support:
|
4.31
3.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.03
 |
MACD |
MACD(12,26):
|
-0.47 |
|
MA(20): |
6.27  |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
6.50 |
Stochastic Oscillator |
%K(14,3):
|
27.25 |
|
MA(250): |
7.20 |
%D(3): |
20.27 |
|
Average Volume(K) |
3-Month: |
83543
|
52-Week |
High:
|
11.41 |
|
10-Days: |
109824 |
Low: |
2.30 |
|
RSI |
RSI(14):
|
45.38 |
Change(%): |
-46.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.440 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.30 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-35.0 |
Shares Float (M) |
11.15 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.99 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
72.7 |
% Held by Institutions |
83.61 |
|
Forward EPS |
-7.850 |
Gross Profit (p.s.) |
0.757 |
Shares Short (K) |
2280 |
|
Book Value (p.s.) |
-2.400 |
EBITDA (p.s.) |
-3.022 |
P/E |
-1.66 |
|
Sales Per Share |
0.962 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.37 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-64.51 |
P/S |
5.93 |
|
Operating Margin |
-326.45 |
Levered Free Cash Flow
(M) |
-37.90 |
P/CF |
-2.41 |
|
|
|
|
|
|
